FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Peptide patents



      
           
This page is updated frequently with new Peptide-related patent applications. Subscribe to the Peptide RSS feed to automatically get the update: related Peptide RSS feeds. RSS updates for this page: Peptide RSS RSS


Date/App# patent app List of recent Peptide-related patents
09/25/14
20140289906
 Compositions having dicamba decarboxylase activity and methods of use patent thumbnailnew patent Compositions having dicamba decarboxylase activity and methods of use
Compositions and methods comprising polynucleotides and polypeptides having dicamba decarboxylase activity are provided. Further provided are nucleic acid constructs, host cells, plants, plant cells, explants, seeds and grain having the dicamba decarboxylase sequences.
09/25/14
20140289905
 Polypeptides having xylanase activity and polynucleotides encoding same patent thumbnailnew patent Polypeptides having xylanase activity and polynucleotides encoding same
Provided are isolated polypeptides having xylanase activity, catalytic domains and cellulose binding domains, and polynucleotides encoding the polypeptides, catalytic domains or cellulose binding domains. Also provided are nucleic acid constructs, vectors and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains or cellulose binding domains..
09/25/14
20140289903
 Enhancing cell wall properties in plants or trees patent thumbnailnew patent Enhancing cell wall properties in plants or trees
The present invention relates to a method for enhancing cell wall properties in plants. The method comprises introducing into the plant, at least one nucleotide construct comprising a nucleic acid molecule operatively linked to a regulatory region active in the plant, wherein said nucleic acid molecule encodes a polypeptide with galactinol synthase (gols)-like activity and growing the plant under conditions that permit the expression of the nucleic acid, thereby enhancing the cell wall property of the plant..
09/25/14
20140289901
 Modulating beta-damascenone in plants patent thumbnailnew patent Modulating beta-damascenone in plants
A mutant, non-naturally occurring or transgenic plant cell comprising: (i) a polynucleotide comprising, consisting or consisting essentially of a sequence encoding a neoxanthin synthase and having at least 60% sequence identity to seq id no:1 or seq id no. 6; (ii) a polypeptide encoded by the polynucleotide set forth in (i); (iii) a polypeptide having at least 66% sequence identity to seq id no:2 or at least 60% sequence identity to seq id no.
09/25/14
20140289900
 Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics patent thumbnailnew patent Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
Provided are isolated polynucleotides at least 80% identical to seq id nos: 1-479, 813-5173, 8511, 8513, 8515, 8517, 8519, 8521, 8523, 9096-9141 and 9142; and isolated polypeptides at least 80% homologous to an amino acid sequence selected from the group consisting of seq id nos: 624, 480-623, 625-812, 5174-7015, 7017-7021, 7024, 7026-8510, 8512, 8514, 8516, 8518, 8520, 8522, 8524, 9143-9177, such as the polypeptides set forth in seq id no:480-812, 5174-8510, 8512, 8514, 8516, 8518, 8520, 8522, 8524, and 9143-9177, nucleic acid constructs comprising same, transgenic cells and plants expressing same and methods of using same for increasing yield, biomass, growth rate, vigor, oil content, fiber yield, fiber quality, nitrogen use efficiency, and/or abiotic stress tolerance of a plant.. .
09/25/14
20140289884
 Nucleotide sequences and corresponding polypeptides conferring improved nitrogen use efficiency characteristics in plants patent thumbnailnew patent Nucleotide sequences and corresponding polypeptides conferring improved nitrogen use efficiency characteristics in plants
Methods and materials for modulating low-nitrogen tolerance levels in plants are disclosed. For example, nucleic acids encoding low nitrogen tolerance-modulating polypeptides are disclosed as well as methods for using such nucleic acids to transform plant cells.
09/25/14
20140289881
 Double-stranded rna patent thumbnailnew patent Double-stranded rna
The present disclosure provides methods and compositions relating to a polynucleotide comprising a dsrna region that is complementary to a particular region of the ns1 gene segment in the influenza virus genome that targets a sequence comprising two overlapping reading frames, one encoding ns1 and the second encoding the nep polypeptide. Thus, the polynucleotide of the invention is able to target two message rnas and is effective at inhibiting the replication of influenza virus in a cell..
09/25/14
20140288661
 Bone tissue engineering by ex vivo stem cells ongrowth into three-dimensional trabecular metal patent thumbnailnew patent Bone tissue engineering by ex vivo stem cells ongrowth into three-dimensional trabecular metal
Adult autologous stem cells cultured on a porous, three-dimensional tissue scaffold-implant for bone regeneration by the use of a hyaluronan and/or dexamethasone to accelerate bone healing alone or in combination with recombinant growth factors or transfected osteogenic genes. The scaffold-implant may be machined into a custom-shaped three-dimensional cell culture system for support of cell growth, reservoir for peptides, recombinant growth factors, cytokines and antineoplastic drugs in the presence of a hyaluronan and/or dexamethasone alone or in combination with growth factors or transfected osteogenic genes, to be assembled ex vivo in a tissue incubator for implantation into bone tissue..
09/25/14
20140288398
 Compositions and devices for the detection of biomarkers in the gastrointestinal tract and methods for making and using them patent thumbnailnew patent Compositions and devices for the detection of biomarkers in the gastrointestinal tract and methods for making and using them
In alternative embodiments, the invention provides compositions such as devices, pills, beads, capsules, products of manufacture, particles, microparticles, nanoparticles, gels, liquid gels, liquid gel capsules, capsules, tablets, geltabs, liquids, sprays, emulsions, suspensions, pastes or yogurts, for the detection and isolation of biomarkers, nucleic acids, proteins or peptides, proteoglycans, lipids, fats, sugars or polysaccharides in the gastrointestinal tract for e.g., detecting the presence of particular exogenous or endogenous nucleic acids, e.g., dna or rna, or proteins, in the gastrointestinal tract, for example, to diagnose the presence of an infectious or exogenous agent such as a virus, a fungus, a parasite, a bacteria, intestinal helminths and protozoan parasites, and the like, or a biomarker such as a cancer-causing or cancer-predisposing allele, e.g., mutations of the kras2 oncogene in pancreatic cancer. In alternative embodiments, compositions of the invention comprise magnetic particles such as a magnetically-responsive microparticle or nanoparticle; a superparamagnetic bead or polystyrene bead; a superparamagnetic fine particle; a ferrimagnetic particle; or, a magnetic microsphere, nanosphere, microbead or nanobeads.
09/25/14
20140288288
 Anti-cd19 antibodies with reduced immunogenicity patent thumbnailnew patent Anti-cd19 antibodies with reduced immunogenicity
Anti-cd19 b4 antibodies with modified variable regions are disclosed. The modified anti-cd19 variable region polypeptides have alterations to one or more framework regions or complementarity determining regions of the heavy chain variable region or light chain variable region, thereby to reduce a t-cell response..
09/25/14
20140288287
new patent Sequence-determined dna fragments encoding trehalose-6p phosphatase proteins
The present invention provides dna molecules that constitute fragments of the genome of a plant, and polypeptides encoded thereby. The dna molecules are useful for specifying a gene product in cells, either as a promoter or as a protein coding sequence or as an utr or as a 3′ termination sequence, and are also useful in controlling the behavior of a gene in the chromosome, in controlling the expression of a gene or as tools for genetic mapping, recognizing or isolating identical or related dna fragments, or identification of a particular individual organism, or for clustering of a group of organisms with a common trait..
09/25/14
20140288272
new patent Antibody purification and purity monitoring
Processes for producing and purifying recombinant proteins are disclosed. In particular, the present disclosure provides processes of producing and purifying multi-subunit proteins expressed in yeast or filamentous fungal cells.
09/25/14
20140288269
new patent Process for the preparation of random polypeptides and employing circular dichroism as a guidance tool for the manufacture of glatiramer acetate
The present invention discloses novel process for the preparation of mixture of polypeptides comprising l-glutamaic acid, l-alanine, l-tyrosine, and l-lysine. By employing circular dichroism as a guidance tool..
09/25/14
20140288268
new patent Method of producing peptide
The present invention is related to a method of producing a peptide, characterized in contacting a reaction mixture with a base after a condensation reaction to hydrolyze while a basic condition is maintained until a ratio of a remaining unreacted active ester of an acid component is decreased to 1% or less in a liquid phase peptide synthesis method. According to the invention, a target peptide of high purity can be simply and efficiently produced by a continuous liquid phase synthesis method.
09/25/14
20140288012
new patent Methods for the prevention and treatment of burn injuries and secondary complications
The disclosure relates to methods for treating a subject suffering from a burn injury or associated complications by administering to the subject an effective amount of an aromatic-cationic peptide. For example, a burn injury may be associated with distant pathophysiological effects, such as hypermetabolism, skeletal muscle dysfunction, and organ damage.
09/25/14
20140288010
new patent Compositions and methods for increasing stem cell survival
Compositions and methods of increasing autophagy in a cell, or population of cells are disclosed. The methods generally include contacting the cell or cells with an effective amount of an agent that increases the bioavailability of an active isoform of sdf-1.
09/25/14
20140288007
new patent Gingipain inhibitory propeptides
The disclosure relates to compounds, peptides or peptidomimetics that inhibit, reduce or prevent protease activity and the use of these compounds, peptides or peptidomimetics to treat or prevent a condition. In particular the condition may be periodontal disease.
09/25/14
20140288002
new patent Extracellular matrix-binding synthetic peptidoglycans
This disclosure provides extracellular matrix-binding synthetic peptidoglycans comprised of one or more synthetic peptides conjugated to a glycan and methods of their use.. .
09/25/14
20140288000
new patent Dual reactivity potent kunitz inhibitor of fibrinolysis
Compositions and methods are disclosed that relate to novel plasmin-inhibiting polypeptides that are structural variants of a human tfpi-2 kunitz-type proteinase first inhibitor domain (kd1). The polypeptides are potent plasmin inhibitors and in certain embodiments have anti-fibrinolytic activity and/or decreased anti-coagulation activity relative to wild-type tfpi-2 kd1 and are not highly immunogenic.
09/25/14
20140287999
new patent Use of natriuretic peptide for treating heart failure
The present invention relates to the use of a natriurectic peptide, such as urodilatin, for treating a patient suffering from heart failure, such as acute decompensated heart failure. Preferably, a composition comprising an effective amount of urodilatin is intravenously administered to the patient continuously through a time period of at least 24 hours and up to 120 hours, preferably at least 48 hours..
09/25/14
20140287995
new patent Stable pharmaceutical formulations of growth factor peptides
The present disclosure provides pharmaceutical formulations including a kidney growth factor peptide and one or more excipients, wherein the formulations have a ph of greater than about 6.8. The disclosure also provides processes for preparing the formulation and products prepared by such processes..
09/25/14
20140287994
new patent Peptides having reduced toxicity that stimulate cholesterol efflux
The present invention provides a family of non-naturally occurring polypeptides having cholesterol efflux activity that parallels that of full-length apolipoproteins (e.g., apo ai and apo e), and having high selectivity for abca1 that parallels that of full-length apolipoproteins. Further, the peptides of the invention have little or no toxicity when administered at therapeutic and higher doses.
09/25/14
20140287991
new patent Hepatitis b virus-binding polypeptides and methods of use thereof
The present invention provides non-naturally occurring polypeptides that specifically bind hepatitis b virus (hbv) dna; and polynucleotides encoding the polypeptides. The present invention further provides methods of detecting hbv dna; methods of detecting a covalently closed circular dna (cccdna) form of hbv; and methods for treating hbv infection..
09/25/14
20140287989
new patent Compounds binding to the bacterial beta ring
The present invention relates to compounds which bind to the hydrophobic pocket of the β clamp, i.e., to the surface of the β ring with which said protein interacts with other proteins of the bacterial replication complex during dna replication. These compounds are derived from the acetylated peptide acqldlf (p6) to improve their affinity to their target..
09/25/14
20140287985
new patent Novel uses of elafin
The invention relates to novel uses of the polypeptide elafin, and/or homologues, derivatives or fragments thereof having inhibitory activity against leukocyte elastase for the prevention and treatment of medical conditions like sirs.. .
09/25/14
20140287957
new patent Isotopic labeling for the measurement of global protein levels and turnover in vivo
An entire complement or plurality of isotopically labeled amino acids are introduced into the diet of a test subject. Sufficient amounts of the isotopically labeled amino acids are provided to the subject in order to ensure that the subject incorporates a large percentage of isotopically labeled amino acids into newly synthesized proteins.
09/25/14
20140287950
new patent Biomarkers and methods for predicting preterm birth
The disclosure provides biomarker panels, methods and kits for determining the probability for preterm birth in a pregnant female. The present disclosure is based, in part, on the discovery that certain proteins and peptides in biological samples obtained from a pregnant female are differentially expressed in pregnant females that have an increased risk of developing in the future or presently suffering from preterm birth relative to matched controls.
09/25/14
20140287948
new patent Biomarkers and methods for predicting preterm birth
The disclosure provides biomarker panels, methods and kits for determining the probability for preterm birth in a pregnant female. The present disclosure is based, in part, on the discovery that certain proteins and peptides in biological samples obtained from a pregnant female are differentially expressed in pregnant females that have an increased risk of developing in the future or presently suffering from preterm birth relative to matched controls.
09/25/14
20140287947
new patent Biomarkers and methods for predicting preeclampsia
The disclosure provides biomarker panels, methods and kits for determining the probability for preeclampsia in a pregnant female. The present disclosure is based, in part, on the discovery that certain proteins and peptides in biological samples obtained from a pregnant female are differentially expressed in pregnant females that have an increased risk of developing in the future or presently suffering from preeclampsia relative to matched controls.
09/25/14
20140287532
new patent Immunoassay method for pro-gastrin-releasing peptide
By using a blood sample in a condition in which a blood coagulation factor is not activated is used as a sample, the degradation of progrp is suppressed, whereby it is possible to store a sample for a long period of time and to improve the accuracy of an assay.. .
09/25/14
20140287528
new patent Incorporation of methyl lysine into polypeptides
The invention relates to a method of making a polypeptide comprising at least one nε-methyl-lysine at a specific site in said polypeptide, said method comprising (a) genetically directing the incorporation of r—nε-methyl-lysine into said polypeptide, wherein r comprises an auxiliary group; and (b) catalysing the removal of r from the polypeptide of (a). In particular the invention relates to such a method wherein genetically directing the incorporation of r—nε-methyl-lysine into said polypeptide comprises arranging for the translation of a rna encoding said polypeptide, wherein said rna comprises an amber codon, and wherein said translation is carried out in the presence of an amber trna charged with r—nε-methyl-lysine..
09/25/14
20140287505
new patent Peptide-presenting surfaces for long-term culture of pluripotent cells
The present invention relates to methods of growing and maintaining pluripotent cells on an insoluble substrate that presents a peptide that binds to glycosaminoglycans, such as heparin. Specifically, methods of growing and maintaining pluripotent cells on substrates having a chemically defined surface presenting at least one peptide having basic amino acid residues separated by one or two hydrophobic amino acid residues..
09/25/14
20140287480
new patent Hbv polymerase mutants
The present invention relates to polymerase hbv mutant polypeptides comprising a mutated polymerase domain which is functionally disrupted for polymerase activity and fusion proteins comprising such polymerase mutant polypeptide. The present invention also relates to a nucleic acid molecule and an expression vector for expressing said polymerase mutant polypeptide as well as a composition which can be used for eliciting an immune response to hbv with the goal of providing a protective or therapeutic effect against hbv infection..
09/25/14
20140287479
new patent Modified lecithin-cholesterol acyltransferase enzymes
The invention provides compounds, pharmaceutical compositions and methods for treating atherosclerosis, coronary heart disease, thrombosis, and for decreasing or prevention of accumulation of cholesterol in a subject by modifying lcat polypeptide.. .
09/25/14
20140287478
new patent Novel glucose dehydrogenase
An object of the present invention is to provide a novel glucose dehydrogenase, a method for producing the glucose dehydrogenase, and applications of the glucose dehydrogenase. An isolated flavin-binding glucose dehydrogenase comprising a polypeptide having an amino acid sequence with 80% or more identity to the amino acid sequence of seq id no: 1, and having glucose dehydrogenase activity is provided..
09/25/14
20140287471
new patent Variant cbh i polypeptides with reduced product inhibition
The present disclosure relates to variant cbh i polypeptides that have reduced product inhibition, and compositions, e.g., cellulase compositions, comprising variant cbh i polypeptides. The variant cbh i polypeptides and related compositions can be used in variety of agricultural and industrial applications.
09/25/14
20140287465
new patent Polypeptides having xylanase activity and polynucleotides encoding same
The present invention relates to polypeptides having xylanase activity, catalytic domains, and carbohydrate binding domains, and polynucleotides encoding the polypeptides, catalytic domains, and carbohydrate binding domains. The present invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains, and carbohydrate binding domains..
09/25/14
20140287464
new patent In vivo unnatural amino acid expression in the methylotrophic yeast pichia pastoris
The invention provides orthogonal translation systems for the production of polypeptides comprising unnatural amino acids in methylotrophic yeast such as pichia pastoris. Methods for producing polypeptides comprising unnatural amino acids in methylotrophic yeast such as pichia pastoris are also provided..
09/25/14
20140287459
new patent Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
Methods for producing heterologous proteins are disclosed. In particular, the present disclosure provides improved methods of producing desired proteins, including multi-subunit proteins such as antibodies, with a higher yield and improved purity.
09/25/14
20140287447
new patent Ultrasensitive methodology for quantifying the kinase catalytic activity of any protein kinase in biological/clinical samples or recombinant/purified proteins using near-infrared-fluorescence (nirf)-labeled, kinase-selective peptide substrates and a combination of kinase-selective inhibitors to define individual kinase activity
A non-radioactive, ultrasensitive methodology for the quantification of protein kinase catalytic activity of any protein kinase in, for example, biological/clinical samples or recombinant/purified proteins, based on using near-infrared-fluorescence (nirf)-labeled peptide substrates that are selective for individual protein kinases and using a combination of kinase-selective inhibitors to define the catalytic activity of individual protein kinases, including but not limited to, a substrate for phosphorylation by a protein kinase comprising a core peptide having the formula: (n-terminus)-arginine-lysine-arginine-serine-arginine-lysine-glutamic-acid-(c-terminus); and an indicator component covalently bonded to the core peptide.. .
09/25/14
20140287445
new patent Flavin-binding glucose dehydrogenase, method for producing flavin-binding glucose dehydrogenase, and glucose measurement method using thereof
A flavin-binding glucose dehydrogenase (fad-gdh), which in addition to having high substrate specificity and adequate desirable heat stability, is suitable for efficient production, preferably using e. Coli, yeast or molds and the like as host cells.
09/25/14
20140287440
new patent Melittin peptide conjugates and methods employing same
Methods and reagents are disclosed for conducting assays for ige specific for honey bee venom allergen. A reagent comprises a conjugate of a small molecule linked to a terminal glycine amino acid of a synthetic 26 amino acid melittin peptide.
09/25/14
20140287433
new patent Means and methods for determining clostridial neurotoxins
This invention relates to a method of determining presence, amount and/or activity of a clostridial neurotoxin in a sample, the method comprising or consisting of the following steps: (a) bringing said sample into contact with a liposome, said liposome comprising (aa) at least one receptor on its outer surface, said receptor being capable of binding said neurotoxin and comprising or consisting of (i) a glycolipid and (ii) a peptide or protein; and (ab) a substrate in its interior, said substrate (i) being cleavable by the peptidase comprised in said neurotoxin and (ii) generating a detectable signal upon cleavage, said detectable signal preferably being generated by (1) the donor of a fret pair, said donor exhibiting increased fluorescence upon cleavage by said peptidase, (2) a luminescent compound formed upon said cleavage, or (3) an enzyme formed upon said cleavage; and (b) determining whether an increase in signal occurs as compared to the absence of said sample, wherein such increase is indicative of the presence of said neurotoxin and/or the degree of such increase is indicative of the amount and/or activity of said neurotoxin in said sample.. .
09/25/14
20140287431
new patent Antibody specific to profilaggrin c-terminal domain, and use thereof
The present invention provides an antibody specific to a c-terminal domain of a human profilaggrin gene, wherein the c-terminal domain is a peptide comprising the amino acid sequence set forth in seq id no:1 or a variant thereof, a method for detecting a filaggrin gene mutation using the antibody, and a kit for the detection.. .
09/25/14
20140287430
new patent Absorbent paper and use thereof for breast cancer detection
Biological samples of mammary fluid or components thereof are obtained using a breast pump device coupled with an absorbent paper or membrane, optionally facilitated by administering oxytocin to the subject. The breast pump device stimulates expression of mammary fluid and provides for collection of diagnostic samples on the absorbent paper or membrane to evaluate breast disease, including cancer.
09/25/14
20140287419
new patent Compositions having dicamba decarboxylase activity and methods of use
Compositions and methods comprising polynucleotides and polypeptides having dicamba decarboxylase activity are provided. Further provided are nucleic acid constructs, host cells, plants, plant cells, explants, seeds and grain having the dicamba decarboxylase sequences.
09/25/14
20140287095
new patent Alpha-lactalbumin enriched whey protein compositions and methods of making and using them
Methods are described for treating a whey protein mixture to increase a relative concentration of α-lactalbumin protein in the mixture. The methods may include the step of adjusting a temperature of the whey protein mixture to about 10° c.
09/25/14
20140287054
new patent Composition comprising bioactive amino acids and/or peptides and marine oil in a stable oil-in-water emulsion, and the use of said composition as a functional or therapeutic composition
The present invention relates to food supplements. Particularly, the present invention relates to a composition comprising marine oil in a stable oil-in-water emulsion, further comprising at least one specific bioactive amino acid or peptide, or derivatives thereof.
09/25/14
20140287034
new patent Stable solid formulation of a gc-c receptor agonist polypeptide suitable for oral administration
Solid, stable formulations of linaclotide suitable for oral administration are described herein as are methods for preparing such formulations. The formulations described herein contain a polypeptide consisting of the amino acid sequence cys cys glu tyr cys cys asn pro ala cys thr gly cys tyr (“linaclotide”; seq id no:1) or a pharmaceutically acceptable salt thereof.
09/25/14
20140287029
new patent Immunogenic epitopes of ngep antigen
The invention provides a peptide comprising a human cytolytic t lymphocyte (ctl) epitope from the human tumor-associated antigen (taa) new gene expressed in prostate (ngep), which can be used in vaccine prevention or therapy of prostate cancer, as well as a nucleic acid encoding the peptide, a vector comprising the nucleic acid, a cell comprising the peptide, nucleic acid, or vector, and compositions thereof.. .
09/25/14
20140287022
new patent Liposomal formulations
The present invention relates to liposomal vaccine compositions, methods for the manufacture thereof, and methods for the use thereof to stimulate an immune response in an animal. These compositions comprise liposomes formed from dimyristoylphosphatidylcholine (“dmpc”); either dimyristoylphosphatidylglycerol (“dmpg”) or dimyristoyltrimethylammonium propane (“dmtap”) or both dmpc and dmtap; and at least one sterol; and an antigenic polypeptide comprising a first polypeptide sequence, and a second polypeptide sequence heterologous the first polypeptide sequence which comprises a transmembrane sequence from a membrane protein, said transmembrane sequence having a number of residues sufficient to cross a lipid bilayer, at least nine contiguous residues of which are predicted to form an alpha helix having a hydrophobicity score of about 0.7 or greater..
09/25/14
20140287006
new patent Degradation-stabilised, biocompatible collagen matrices
The present invention relates to degradation-stabilised, biocompatible collagen matrices which are distinguished in particular by the fact that they contain soluble collagen and peptide constituents, to processes for the preparation of such collagen matrices, which processes include in particular chemical crosslinking with an epoxy-functional crosslinking agent, and to the use of the collagen matrices according to the invention as a cosmetic or pharmaceutical agent, in particular for topical use, and as a wound treatment agent, as an implant or as a haemostatic agent in humans or animals, and as a scaffold for cell population in the biotechnology, basic research and tissue engineering field.. .
09/25/14
20140287001
new patent Compositions useful for the treatment of gastrointestinal disorders
This invention provides novel peptides and methods to prevent, control, and treat an inflammation, cancer and other disorders, particularly of the gastrointestinal tract and the lung by administering at least one agonist of guanalyte cyclase receptor either alone or in combination with a compound selected from i) 5-aminosalicyclic acid (5-asa) or a derivative or a pharmaceutically acceptable salt thereof; ii) mercaptopurine; or iii) an anti-tnf therapy.. .


Popular terms: [SEARCH]



Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Peptide for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Peptide with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.2593

7990

2 - 1 - 176